PIK3C3 and neoplasm: Young and co-workers have targeted type I (p110α) and type III (vacuolar protein sorting 34, Vps34) PI3Ks using SAR405, a pyrimidine-based small molecule, to inhibit these kinases to reduce tumour growth and induce autophagy.